After menopause, individuals with cardiovascular disease and weight gain may face a higher risk of breast cancer, recent ...

Stratifying body mass index (BMI) categories by waist circumference (WC) thresholds improves mortality risk prediction in ...

While a healthy lifestyle naturally has important benefits, yet seeking weight loss alone might not give an adequate picture ...

HealthDay News — The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than traditional body mass index (BMI), according to a study published ...

• Future studies should report their results by age, gender, race/ethnicity; include the full data; include adverse events and other outcomes; control for both diet and physical activity in their ...

Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 ...

Rhythm said results of the recent trial were also consistent with BMI reductions achieved with setmelanotide therapy in similar patient populations in past trials. Setmelanotide, an existing ...

Obesity in itself is not a contraindication to radical prostatectomy, but it remains a risk factor for poor overall survival. Although obesity increases the technical complexity of radical ...

Rhythm Pharmaceuticals' experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said on Monday, sending its shares 24% higher in ...

Rhythm Pharma (RYTM) stock gains as the company's experimental therapy bivamelagon shows promise in Phase 2 trial for rare acquired hypothalamic obesity. Read more here.